Share Price and Basic Stock Data
Last Updated: November 26, 2025, 7:54 pm
| PEG Ratio | 0.00 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
IEL Ltd operates in the Edible Oils and Solvent Extraction industry, with its share price currently standing at ₹7.72 and a market capitalization of ₹101 Cr. The company’s revenue performance has shown notable fluctuations over recent quarters. For example, sales increased sharply from ₹0.19 Cr in June 2022 to ₹5.91 Cr by December 2022, showcasing a significant upward trend. However, this was followed by a decline to ₹1.03 Cr in March 2023, before rebounding to ₹9.12 Cr in March 2024. This spike indicates a potential recovery phase after a period of volatility. The trailing twelve months (TTM) revenue stood at ₹0.41 Cr, suggesting that the company has faced challenges in sustaining its revenue momentum. The sales figures for subsequent quarters indicate inconsistency, with sales dropping to ₹0.00 Cr in September 2024, which raises concerns about future operational stability.
Profitability and Efficiency Metrics
IEL Ltd’s profitability metrics reveal a challenging operational landscape. The reported net profit for FY 2025 was ₹0.43 Cr, but this comes after a significant net loss of ₹0.89 Cr in the TTM period. The operating profit margin (OPM) displayed considerable volatility, recorded at 15.21% in FY 2023 but dropping to just 9.90% in FY 2025. Furthermore, the return on equity (ROE) and return on capital employed (ROCE) stood at 1.91% and 2.51%, respectively, which are significantly below industry averages and suggest inefficiencies in capital utilization. The interest coverage ratio (ICR) was exceptionally high at 385.94x, indicating that the company has no immediate interest obligations, which is a positive aspect. However, the cash conversion cycle (CCC) of 0.59 days suggests a tight operating cycle, potentially limiting liquidity and flexibility in operations.
Balance Sheet Strength and Financial Ratios
The financial health of IEL Ltd is characterized by a lack of reported borrowings, which may seem advantageous at first glance. However, the absence of reserves and the reliance on public shareholders, who constitute 99.96% of the ownership, raises concerns about capital structure and financial stability. The price-to-book value (P/BV) ratio is reported at 1.37x, indicating a premium over the book value per share of ₹3.44, which may reflect market confidence but also implies that investors are paying more than the intrinsic value of the company’s assets. The current and quick ratios are extraordinarily high at 67.44x, suggesting excessive liquidity that may not be effectively utilized. This may point to inefficiencies in asset management, indicating that while the company is liquid, it may not be using its resources to generate adequate returns.
Shareholding Pattern and Investor Confidence
IEL Ltd’s shareholding pattern reveals a significant shift in ownership dynamics. Promoters’ stake has declined from 65.94% in December 2022 to just 0.96% by March 2025, indicating a potential loss of confidence from the original owners. Meanwhile, the public’s shareholding increased dramatically from 33.93% in December 2022 to 99.01% in March 2025. This transition suggests a growing retail investor interest but also raises questions about the long-term vision and management stability. The number of shareholders has surged from 2,492 in December 2022 to 36,511 in September 2025, reflecting a heightened interest in the stock. However, the minimal presence of institutional investors (DIIs at 0.03%) points to a lack of institutional confidence, which could be a red flag for prospective investors.
Outlook, Risks, and Final Insight
The outlook for IEL Ltd hinges on its ability to stabilize revenue and improve profitability. The inconsistent sales figures and declining promoter stake could pose risks to operational continuity and strategic direction. While the absence of debt and high liquidity may provide some buffer, the company must address its inefficiencies to leverage these strengths. The decline in the OPM and low ROE suggests that without operational improvements, sustaining investor confidence may prove challenging. Risks include potential market volatility in the edible oils sector and ongoing operational inefficiencies. In a scenario where IEL Ltd successfully implements strategic initiatives to enhance revenue generation and profitability, it could attract institutional investors and stabilize its market position. Conversely, continued financial instability may lead to further declines in shareholder confidence and market valuation.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of IEL Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| IEL Ltd | 95.2 Cr. | 7.30 | 10.3/3.87 | 3.37 | 0.00 % | 2.51 % | 1.91 % | 1.00 | |
| Evexia Lifecare Ltd | 323 Cr. | 1.72 | 4.40/1.52 | 226 | 3.02 | 0.00 % | 0.30 % | 0.32 % | 1.00 |
| Diligent Industries Ltd | 68.9 Cr. | 2.89 | 5.12/1.45 | 26.8 | 2.79 | 0.00 % | 7.06 % | 6.09 % | 1.00 |
| CIAN Agro Industries & Infrastructure Ltd | 4,004 Cr. | 1,431 | 3,633/321 | 1,973 | 33.0 | 0.00 % | 8.54 % | 1.06 % | 10.0 |
| BCL Industries Ltd | 1,009 Cr. | 34.3 | 58.3/33.0 | 9.69 | 28.9 | 0.76 % | 13.2 % | 13.0 % | 1.00 |
| Industry Average | 10,572.64 Cr | 172.62 | 161.67 | 33.77 | 0.18% | 14.09% | 12.05% | 4.00 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.19 | 3.94 | 5.91 | 1.03 | 1.61 | 1.04 | 5.49 | 9.12 | 5.31 | 0.00 | 0.40 | 0.01 | 0.00 |
| Expenses | 0.02 | 2.58 | 4.97 | 1.11 | 1.52 | 1.08 | 5.35 | 8.93 | 5.12 | 0.05 | 0.13 | 0.27 | 0.78 |
| Operating Profit | 0.17 | 1.36 | 0.94 | -0.08 | 0.09 | -0.04 | 0.14 | 0.19 | 0.19 | -0.05 | 0.27 | -0.26 | -0.78 |
| OPM % | 89.47% | 34.52% | 15.91% | -7.77% | 5.59% | -3.85% | 2.55% | 2.08% | 3.58% | 67.50% | -2,600.00% | ||
| Other Income | 0.00 | 0.00 | 0.00 | 0.03 | 0.00 | 0.00 | 0.00 | 0.00 | 0.22 | 0.22 | 0.02 | 0.00 | 0.05 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.02 | 0.02 | 0.02 | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Profit before tax | 0.15 | 1.34 | 0.92 | -0.05 | 0.08 | -0.05 | 0.13 | 0.18 | 0.40 | 0.16 | 0.28 | -0.27 | -0.74 |
| Tax % | 0.00% | 0.00% | 0.00% | -20.00% | 25.00% | 0.00% | 15.38% | 27.78% | 25.00% | 18.75% | 25.00% | -18.52% | 0.00% |
| Net Profit | 0.15 | 1.34 | 0.92 | -0.04 | 0.06 | -0.05 | 0.11 | 0.14 | 0.31 | 0.13 | 0.21 | -0.22 | -0.74 |
| EPS in Rs | 0.01 | 0.10 | 0.07 | -0.00 | 0.00 | -0.00 | 0.01 | 0.01 | 0.02 | 0.01 | 0.02 | -0.02 | -0.06 |
Last Updated: August 19, 2025, 1:35 pm
Below is a detailed analysis of the quarterly data for IEL Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 0.01 Cr. (Mar 2025) to 0.00 Cr., marking a decrease of 0.01 Cr..
- For Expenses, as of Jun 2025, the value is 0.78 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.27 Cr. (Mar 2025) to 0.78 Cr., marking an increase of 0.51 Cr..
- For Operating Profit, as of Jun 2025, the value is -0.78 Cr.. The value appears to be declining and may need further review. It has decreased from -0.26 Cr. (Mar 2025) to -0.78 Cr., marking a decrease of 0.52 Cr..
- For OPM %, as of Jun 2025, the value is 0.00%. The value appears strong and on an upward trend. It has increased from -2,600.00% (Mar 2025) to 0.00%, marking an increase of 2,600.00%.
- For Other Income, as of Jun 2025, the value is 0.05 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Mar 2025) to 0.05 Cr., marking an increase of 0.05 Cr..
- For Interest, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Depreciation, as of Jun 2025, the value is 0.01 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.01 Cr..
- For Profit before tax, as of Jun 2025, the value is -0.74 Cr.. The value appears to be declining and may need further review. It has decreased from -0.27 Cr. (Mar 2025) to -0.74 Cr., marking a decrease of 0.47 Cr..
- For Tax %, as of Jun 2025, the value is 0.00%. The value appears to be increasing, which may not be favorable. It has increased from -18.52% (Mar 2025) to 0.00%, marking an increase of 18.52%.
- For Net Profit, as of Jun 2025, the value is -0.74 Cr.. The value appears to be declining and may need further review. It has decreased from -0.22 Cr. (Mar 2025) to -0.74 Cr., marking a decrease of 0.52 Cr..
- For EPS in Rs, as of Jun 2025, the value is -0.06. The value appears to be declining and may need further review. It has decreased from -0.02 (Mar 2025) to -0.06, marking a decrease of 0.04.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: November 15, 2025, 3:07 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1.48 | 0.02 | -0.06 | 0.00 | 1.26 | 2.12 | 3.87 | 0.96 | 0.64 | 10.19 | 17.26 | 6.16 | 0.41 |
| Expenses | 2.11 | 2.15 | 0.29 | 0.32 | 1.42 | 2.22 | 3.98 | 1.11 | 0.82 | 8.64 | 16.88 | 5.55 | 1.31 |
| Operating Profit | -0.63 | -2.13 | -0.35 | -0.32 | -0.16 | -0.10 | -0.11 | -0.15 | -0.18 | 1.55 | 0.38 | 0.61 | -0.90 |
| OPM % | -42.57% | -10,650.00% | -12.70% | -4.72% | -2.84% | -15.62% | -28.12% | 15.21% | 2.20% | 9.90% | -219.51% | ||
| Other Income | 0.03 | 0.17 | 0.05 | 0.20 | 0.20 | 0.32 | 0.22 | 0.38 | 0.59 | 0.87 | 0.00 | 0.01 | 0.07 |
| Interest | 0.01 | 0.00 | 0.03 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.05 | 0.17 | 0.11 | 0.10 | 0.10 | 0.09 | 0.09 | 0.09 | 0.09 | 0.07 | 0.03 | 0.03 | 0.04 |
| Profit before tax | -0.66 | -2.13 | -0.44 | -0.22 | -0.07 | 0.13 | 0.02 | 0.14 | 0.32 | 2.35 | 0.35 | 0.59 | -0.87 |
| Tax % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -0.43% | 25.71% | 25.42% | |
| Net Profit | -0.67 | -2.13 | -0.44 | -0.22 | -0.07 | 0.12 | 0.02 | 0.14 | 0.32 | 2.37 | 0.26 | 0.43 | -0.89 |
| EPS in Rs | -0.05 | -0.16 | -0.03 | -0.02 | -0.01 | 0.01 | 0.00 | 0.01 | 0.02 | 0.18 | 0.02 | 0.03 | -0.07 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -217.91% | 79.34% | 50.00% | 68.18% | 271.43% | -83.33% | 600.00% | 128.57% | 640.62% | -89.03% | 65.38% |
| Change in YoY Net Profit Growth (%) | 0.00% | 297.25% | -29.34% | 18.18% | 203.25% | -354.76% | 683.33% | -471.43% | 512.05% | -729.65% | 154.41% |
IEL Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 77% |
| 5 Years: | 10% |
| 3 Years: | 113% |
| TTM: | -98% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 85% |
| 3 Years: | 10% |
| TTM: | -222% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 14% |
| 5 Years: | 77% |
| 3 Years: | -1% |
| 1 Year: | 28% |
| Return on Equity | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 12% |
| 3 Years: | 12% |
| Last Year: | 2% |
Last Updated: September 5, 2025, 3:41 pm
No data available for the Balance Sheet data table.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 167.70 | 0.00 | 0.00 | 353.41 | 6.89 | 20.75 | 114.06 | 285.16 | 82.03 | 35.10 | 0.59 | |
| Inventory Days | 85.59 | 0.00 | 300.40 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 22.52 | 0.00 | ||
| Days Payable | 402.76 | 694.47 | 34.34 | |||||||||
| Cash Conversion Cycle | -149.47 | 0.00 | 0.00 | -40.66 | 6.89 | 20.75 | 114.06 | 285.16 | 82.03 | 23.29 | 0.59 | |
| Working Capital Days | -199.76 | -21,170.00 | -8,942.50 | 8.69 | -13.77 | -72.62 | 15.21 | 182.50 | 26.51 | 32.36 | 1,240.76 | |
| ROCE % | -11.26% | -51.31% | -13.92% | -8.43% | -2.48% | 0.82% | 0.80% | 5.39% | 11.31% | 96.30% | 17.50% | 2.51% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 1.00 | 1.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 0.03 | 0.08 | 7.09 | 0.96 | 0.41 |
| Diluted EPS (Rs.) | 0.03 | 0.08 | 7.09 | 0.96 | 0.41 |
| Cash EPS (Rs.) | 0.03 | 0.08 | 7.29 | 1.22 | 0.67 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 3.44 | 0.36 | 2.90 | -4.19 | -5.15 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 3.44 | 0.36 | 2.90 | 6.22 | 5.26 |
| Revenue From Operations / Share (Rs.) | 0.47 | 5.13 | 30.53 | 1.91 | 2.87 |
| PBDIT / Share (Rs.) | 0.04 | 0.11 | 7.25 | 1.22 | 0.68 |
| PBIT / Share (Rs.) | 0.04 | 0.10 | 7.05 | 0.96 | 0.41 |
| PBT / Share (Rs.) | 0.04 | 0.10 | 7.06 | 0.95 | 0.41 |
| Net Profit / Share (Rs.) | 0.03 | 0.07 | 7.09 | 0.95 | 0.41 |
| PBDIT Margin (%) | 10.02 | 2.22 | 23.74 | 63.86 | 23.72 |
| PBIT Margin (%) | 9.47 | 2.02 | 23.09 | 50.45 | 14.54 |
| PBT Margin (%) | 9.44 | 2.02 | 23.13 | 50.07 | 14.29 |
| Net Profit Margin (%) | 7.00 | 1.50 | 23.22 | 50.07 | 14.29 |
| Return on Networth / Equity (%) | 0.96 | 20.98 | 244.77 | -22.85 | -7.97 |
| Return on Capital Employeed (%) | 1.26 | 16.33 | 126.07 | 7.95 | 3.73 |
| Return On Assets (%) | 0.91 | 6.83 | 66.91 | 6.88 | 3.39 |
| Long Term Debt / Equity (X) | 0.02 | 0.00 | 0.00 | -0.01 | -0.01 |
| Total Debt / Equity (X) | 0.02 | 0.00 | 0.00 | -0.01 | -0.01 |
| Asset Turnover Ratio (%) | 0.24 | 4.69 | 2.49 | 0.14 | 0.22 |
| Current Ratio (X) | 67.44 | 2.18 | 1.99 | 1.88 | 1.33 |
| Quick Ratio (X) | 67.44 | 1.56 | 1.99 | 1.88 | 1.33 |
| Interest Coverage Ratio (X) | 385.94 | 695.97 | 897.67 | 169.74 | 95.84 |
| Interest Coverage Ratio (Post Tax) (X) | 270.69 | 471.35 | 876.31 | 134.10 | 58.75 |
| Enterprise Value (Cr.) | 36.97 | 27.89 | 31.04 | 20.33 | 4.21 |
| EV / Net Operating Revenue (X) | 6.00 | 1.63 | 3.05 | 31.83 | 4.39 |
| EV / EBITDA (X) | 59.86 | 73.40 | 12.82 | 49.84 | 18.50 |
| MarketCap / Net Operating Revenue (X) | 9.95 | 1.60 | 3.05 | 30.72 | 3.50 |
| Price / BV (X) | 1.37 | 22.40 | 32.12 | -14.02 | -1.95 |
| Price / Net Operating Revenue (X) | 9.95 | 1.60 | 3.05 | 30.74 | 3.50 |
| EarningsYield | 0.01 | 0.01 | 0.07 | 0.01 | 0.04 |
After reviewing the key financial ratios for IEL Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 0.03. This value is below the healthy minimum of 5. It has decreased from 0.08 (Mar 24) to 0.03, marking a decrease of 0.05.
- For Diluted EPS (Rs.), as of Mar 25, the value is 0.03. This value is below the healthy minimum of 5. It has decreased from 0.08 (Mar 24) to 0.03, marking a decrease of 0.05.
- For Cash EPS (Rs.), as of Mar 25, the value is 0.03. This value is below the healthy minimum of 3. It has decreased from 0.08 (Mar 24) to 0.03, marking a decrease of 0.05.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 3.44. It has increased from 0.36 (Mar 24) to 3.44, marking an increase of 3.08.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 3.44. It has increased from 0.36 (Mar 24) to 3.44, marking an increase of 3.08.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 0.47. It has decreased from 5.13 (Mar 24) to 0.47, marking a decrease of 4.66.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 0.04. This value is below the healthy minimum of 2. It has decreased from 0.11 (Mar 24) to 0.04, marking a decrease of 0.07.
- For PBIT / Share (Rs.), as of Mar 25, the value is 0.04. This value is within the healthy range. It has decreased from 0.10 (Mar 24) to 0.04, marking a decrease of 0.06.
- For PBT / Share (Rs.), as of Mar 25, the value is 0.04. This value is within the healthy range. It has decreased from 0.10 (Mar 24) to 0.04, marking a decrease of 0.06.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 0.03. This value is below the healthy minimum of 2. It has decreased from 0.07 (Mar 24) to 0.03, marking a decrease of 0.04.
- For PBDIT Margin (%), as of Mar 25, the value is 10.02. This value is within the healthy range. It has increased from 2.22 (Mar 24) to 10.02, marking an increase of 7.80.
- For PBIT Margin (%), as of Mar 25, the value is 9.47. This value is below the healthy minimum of 10. It has increased from 2.02 (Mar 24) to 9.47, marking an increase of 7.45.
- For PBT Margin (%), as of Mar 25, the value is 9.44. This value is below the healthy minimum of 10. It has increased from 2.02 (Mar 24) to 9.44, marking an increase of 7.42.
- For Net Profit Margin (%), as of Mar 25, the value is 7.00. This value is within the healthy range. It has increased from 1.50 (Mar 24) to 7.00, marking an increase of 5.50.
- For Return on Networth / Equity (%), as of Mar 25, the value is 0.96. This value is below the healthy minimum of 15. It has decreased from 20.98 (Mar 24) to 0.96, marking a decrease of 20.02.
- For Return on Capital Employeed (%), as of Mar 25, the value is 1.26. This value is below the healthy minimum of 10. It has decreased from 16.33 (Mar 24) to 1.26, marking a decrease of 15.07.
- For Return On Assets (%), as of Mar 25, the value is 0.91. This value is below the healthy minimum of 5. It has decreased from 6.83 (Mar 24) to 0.91, marking a decrease of 5.92.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.02. This value is below the healthy minimum of 0.2. It has increased from 0.00 (Mar 24) to 0.02, marking an increase of 0.02.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.02. This value is within the healthy range. It has increased from 0.00 (Mar 24) to 0.02, marking an increase of 0.02.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.24. It has decreased from 4.69 (Mar 24) to 0.24, marking a decrease of 4.45.
- For Current Ratio (X), as of Mar 25, the value is 67.44. This value exceeds the healthy maximum of 3. It has increased from 2.18 (Mar 24) to 67.44, marking an increase of 65.26.
- For Quick Ratio (X), as of Mar 25, the value is 67.44. This value exceeds the healthy maximum of 2. It has increased from 1.56 (Mar 24) to 67.44, marking an increase of 65.88.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 385.94. This value is within the healthy range. It has decreased from 695.97 (Mar 24) to 385.94, marking a decrease of 310.03.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 270.69. This value is within the healthy range. It has decreased from 471.35 (Mar 24) to 270.69, marking a decrease of 200.66.
- For Enterprise Value (Cr.), as of Mar 25, the value is 36.97. It has increased from 27.89 (Mar 24) to 36.97, marking an increase of 9.08.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 6.00. This value exceeds the healthy maximum of 3. It has increased from 1.63 (Mar 24) to 6.00, marking an increase of 4.37.
- For EV / EBITDA (X), as of Mar 25, the value is 59.86. This value exceeds the healthy maximum of 15. It has decreased from 73.40 (Mar 24) to 59.86, marking a decrease of 13.54.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 9.95. This value exceeds the healthy maximum of 3. It has increased from 1.60 (Mar 24) to 9.95, marking an increase of 8.35.
- For Price / BV (X), as of Mar 25, the value is 1.37. This value is within the healthy range. It has decreased from 22.40 (Mar 24) to 1.37, marking a decrease of 21.03.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 9.95. This value exceeds the healthy maximum of 3. It has increased from 1.60 (Mar 24) to 9.95, marking an increase of 8.35.
- For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
Unable to fetch valid data for stock valuation.Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in IEL Ltd:
- Net Profit Margin: 7%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 1.26% (Industry Average ROCE: 14.09%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 0.96% (Industry Average ROE: 12.05%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 270.69
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 67.44
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 0 (Industry average Stock P/E: 161.67)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.02
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 7%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Edible Oils & Solvent Extraction | Office No 53, 6th Floor, Sanidhya Complex, Near Devnandan Mall, Ahmedabad Gujarat 380006 | iellimitedamd@gmail.com www.ielindia.in |
| Management | |
|---|---|
| Name | Position Held |
| Ms. Ajay Bholanath Gupta | Chairman & Managing Director |
| Mr. Arpit Singh | Non Exe.Non Ind.Director |
| Ms. Juhi Sajwani | Independent Director |
| Ms. Avani Shah | Independent Director |
| Ms. Aastha Jain | Independent Director |
| Ms. Ami Priyank Bhanshali | Independent Director |
| Ms. Mokshi Prakshbhai Shah | Independent Director |